Purpose: Because we have found that random mucosal biopsies have no additional prognostic value to conventional histopathology, we studied biopsies of histologically normal bladder mu cosa with several molecular markers believed to be associated with the development of transi tional cell carcinoma.
O f the patients presenting with transitional cell carcinoma (TCC) of the urinary bladder, approximately 6 5 % have su perficial tumors (^p T l). The remaining patients present with invasive (^p T 2) or metastatic (N + , M + ) disease.1 Su perficial bladder cancer is characterized by inconsistent bio logical behavior. The risk of tumor recurrence and progres sion can vary. Of all superficial bladder cancer patients a small group will only have 1 episode of superficial tumor. After transurethral resection (TUR) they will be without recurrences with or without adjuvant treatment ("low risk tumors"). Another small group of patients will present with "high risk" tumors from the start. These patients are at risk for progression to invasive disease, despite maximal adju vant treatment. The majority of patients, however, will have regularly recurrent bladder tumors without obvious signs of progression ("intermediate risk"). To differentiate between these risk groups prognostic factors are used, such as tumor grade, stage, size and multiplicity, recurrence rate, and pos sibly the result of random mucosal biopsies. As we have shown, these selected mucosal biopsies are of no additional value to conventional histopathology in a multivariate anal ysis.2 However, the high recurrence rate and multiplicity in superficial bladder cancer suggest that the entire mucosa is primed to become malignant (field defect theory). Therefore, we looked at molecular changes in mucosal biopsies, using several markers associated with development of T C C . W e analyzed normal-appearing mucosa in 6 groups of patients with an increasing stage and grade of bladder tumors. The expression of these markers in normal mucosa is believed to be a potential indicator of a mucosal field defect, and might be an additional prognostic factor in the work-up of patients with bladder cancer.
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M A T E R I A L S A N D M E T H O D S
In all, 6 groups of patients were identified. For each group 10 patients were selected (table 1). In every patient urethrocystoscopy was done, and cold-cup mucosal biopsies were taken from normal-appearing mucosa. At least 2 biopsies were taken from the left and right lateral bladder wall. In case of a tumor on one of the lateral walls, the biopsy was taken 2 cm. away from the tumor. Biopsies were stored in liquid nitrogen. Serial frozen sections were obtained from the biopsy material. One section from each series for the immunohistochemical analysis was stained with hematoxylin and eosin to determine the histopathological diagnosis. In a pilot study we tested the feasibility of this technique, and the results showed that biopsies stored in this manner were adequate for these investigations. There were no artifacts due to storage in liquid nitrogen and there was little mechan ical damage, W e studied the expression of cytokeratin (CK18-2), fi bronectin, E-cadherin (HECD-1), intercellular adhesion mol ecule (I-CAM), human leukocyte antigen (H L A ) class I, H L A class II and the epidermal growth factor receptor (EGF-R). The antigen G250, which is renal cell carcinoma specific with only minor expression on the major bile ducts, was used as a negative control. The monoclonal antibodies (MAbs) used for this testing are listed in table 2. Expression of the M Abs was tested by means of direct immunohis to chemical staining for MAbs for H L A class I and II3 and indirect methods for the other MAbs. The indirect immunoperoxidase technique used in this study was performed at room temperature. The frozen sections were fixed with acetone for 10 minutes and air dried. Preincubation was done with 10% normal rabbit serum in phosphate-buffered saline (PBS) for 30 minutes and subse quently with primary antibody for 1 hour. The primary an tibody concentration was typically determined by using se rial dilutions on a positive control. The optimal concentration was chosen as the lowest with which a clear positive signal was obtained at a minimal background. The optimal dilution is also indicated in Following brief rinsing with water, the sections were incu bated with 0 .5 % C u S 0 4 (in 0 .9 % NaCl) for 5 minutes to intensify the reactions. After rinsing with water, the sections were counterstained with hematoxylin, dehydrated and mounted. Control experiments were done with 1% B S A in PB S instead of primary antibody. Staining was scored semiquantitatively by 3 different in vestigators. For each antigen a total of 10 high-power fields was scored. In each high-power field the percentage of clearly positive staining cells was estimated, after determination of the optimal primary antibody concentration. No variations in intensity of staining were considered.
For statistical analysis of the 6 different groups of patients the Kendall test against rank-correlation was used.
RESULTS
First, conventional histology of the biopsies was studied. Only patients in whom this histology was normal, that is, without mucosal denudation, dysplasia or tumor, were eval uated. The remaining number of patients in each group was 8 in group 1 (benign disease), 10 in group 2 (low risk), 9 in group 3 (intermediate risk), 7 in group 4 {high risk), 6 in group 5 (progressive superficial tumors in spite of optimal conser vative therapy) and 5 in group 6 (invasive or disseminated tumors at presentation).
The epithelial structures in the biopsy specimens were analyzed with the various antibodies. The results of the antibody expression, together with the results of the statis tical analysis are listed in table 3. G250 expression, used as a control for nonspecific staining, was negative in all cases.
The epithelial phenotype was confirmed by using cytokera tin 18 (CK18-2), an epithelial-specific intermediate filament protein that is known to be expressed in all cell layers of the mucosa. CK18-2 was chosen because the epitope recognized by this antibody is, unlike the one recognized by R G E 53, not partially masked in normal urothelium. Although cytokera tin 18 expression was not used as a tumor marker, aberrant expression patterns have to be kept in mind in relation to stage and grade of T C C .4 In our study no significant changes in CK18-2 expression were noted (p = .04) although expres sion decreased in the higher groups.
Evidence for gross changes in the extracellular matrix composition could result in changes in fibronectin (FN) stain ing, which is a component of the extracellular matrix. Dis ruption of the F N pattern and the subsequent decreased expression are associated with neoplastic changes in vitro.5 W e found no significant variation in either the pattern or intensity.
A recently described progression marker is I-CAM class 1, even though its role has not been studied extensively in bladder cancer. There were no changes found in the expres sion of this protein in the various groups (p = .07).
A protein that marks epithelial integrity is E-cadherin. E-cadherin expression is restricted to epithelial tissues6'7 and is homogeneously; expressed in the urothelium at cell cell contacts.8 All biopsies in this study expressed E-cadherin homogeneously; hence no indication for microinvasive subpopulations was evident in any of the groups (p = .08).
Loss or decrease in the expression of histocompatibility antigens was reported for T C C and may be instrumental in escape from immune surveillance. Surprisingly, we found a significant increase in the expression of H L A I in the various groups (p = .003). Changes in expression of H L A II showed no significant differences between groups (p = .31).
A well-described progression marker is EGF-R, which is normally expressed in the basal layers of the urothelium. Expression of EGF-R in both superficial and deeper layers of the mucosa, the so called malignant distribution, is associ ated with T C C .9 W e found this malignant distribution of EGF-R in all patient groups and also in the mucosa of pa tients without bladder cancer. Statistical analysis showed a significant correlation between an increased EGF-R expres sion and a higher stage of the primary bladder tumor (p = .0001).
D IS C U S S IO N
Because superficial bladder cancer is characterized by an unpredictable clinical course, prognostic factors are of partic ular interest. The high recurrence rate and multiplicity led some investigators to formulate a "field defect theory", pre suming that carcinogenic factors in urine can affect the whole mucosa. Therefore, selected mucosal biopsies were believed to carry prognostic value. However, the value of histologic examination of mucosal biopsies of normal-appearing mucosa is contradictory and probably very limited.2 W e investigated such biopsies with several markers, commonly used to study the development of TCC, in 6 groups of patients with tumors of increasing clinically malignant behavior. Of some mark ers, like cytokeratin 18 and fibronectin, little is known about the relation of the expression of these markers to TCC be havior, The relation of I-CAM expression and cancer has only been described recently. In kidney cancer an increased I- 22 Only scant data on the relation between HLA-II ex pression and bladder cancer have been published and al though HLA-II expression was found in bladder cancer and correlated with B C G therapy23,24 and was induced by cyto kines,25 no correlation has been found between HLA-II ex pression and tumor aggressiveness. 24, 26 A consistent value of the epidermal growth factor receptor (EGF-R) in T C C has been recently reported.9-27 Normally, EGF-R is found only on the basal layer of epithelial cells. In bladder tumors the urinary concentration of E G F can be decreased, but EGF-R expression in tumors is higher than in normal urothelium. Messing found increased expression of EGF-R in superficial and deeper layers of the mucosa ("m a lignant distribution") in low and high grade TCC, as well as in normal-appearing mucosa of patients with T C C elsewhere in the bladder.9 This might favor interaction of premalign ant and malignant mucosa with urinary E G F . Neal et al. studied 101 patients with newly diagnosed bladder cancer, with a follow-up of 30 months.27 They found an association between strong positive immunohis to chemical staining of the EGF-R (48 tumors) and high stage bladder cancer (p <0.001). In pTa and pTl lesions (52 patients) EGF-R positivity was associ ated with multiplicity, short time to recurrence and high recurrence rate. In a multivariate analysis EGF-R positivity was predictive of bladder cancer related death in all 101 patients (relative risk 3.42, p <0.001). In 52 patients with superficial T C C , EGF-R positivity was predictive for time to recurrence (relative risk 2.28, p <0.03) and time to progres sion (relative risk 22.12, p < 0.001). For human bladder can cer cell lines transplanted into nude mice, a higher EGF-R expression was also found in the invasive cell lines than in the noninvasive lines. 28 If the theory of a "field defect" is correct, premalignant abnormalities could be present in normal mucosa of bladder cancer patients.
Sidransky et al. examined 13 tumors from cystectomy spec imens from 4 women and found that, in each patient, all the tumors shared 2 chromosomal abnormalities (inactivation of the same X chromosome and loss of the same allele on chro mosome 9q).29 Loss of chromosome 17p and 18q was not the same in each patient, but these losses are late events in tumor progression. The authors concluded that these tumors arise from a single transformed cell after variable subse quent genetic alterations. This finding could indicate that, over time, (pre)malignant cells remain present in the bladder and can be detected. Similar findings about clonality of blad der tumors were published by Miyao et al., who found con cordance in loss of heterozygosity of chromosome 9 and 17p and p53 mutations between primary tumors and lymph node metastases in 14 patients. 30 Flow cytometric measurement of D N A ploidy of untreated bladder tumors and grossly normal distant bladder mucosa revealed comparable degrees of aneuploidy, also indicating the malignant potential of the nor mal mucosa. 31 Rao et al. investigated biochemical markers in tumors, adjacent bladder mucosa and random distant blad der mucosa in 30 patients with superficial bladder tumors. 32 Although there was a decreasing degree of changes in most of these markers from the tumor to the distant mucosa, vari able degrees of marker changes in morphologically normal mucosa were present. G-actin, for example, was altered in 58% of distant biopsy specimens in 30 patients compared with 0 in 6 normals. Abnormal EGF-R expression was found in ± 4 0 % of the distant mucosal biopsies, These data suggest that chromosomal and biochemical ab normalities can be present in normal-appearing mucosa. Therefore, investigation of normal-appearing mucosa re mains an interesting approach, with possible prognostic con sequences. The difference in our approach is that we com 
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PROGNOSTIC FACTORS IN BLADDER CANCER pared different groups of patients with an increasing stage of primary tumor. Looking at the markers we used, one might expect a rise in EGF-R expression and a fall in H L A class I and E-cadherin expression with increasing malignant poten tial of the mucosa. The relation between H L A class II, cytokeratin, fibronectin and I-CAM expression and T C C behavior is inconsistent. The fact that most markers show no changes in our study indicates that normal mucosa in patients with bladder tumor reacts similarly to normal mucosa, and this does not support the "field defect" theory. The increasing HLA-I expression is the opposite of what was expected and is difficult to understand. Like others, we have found an abnor mal distribution of EGF-R expression (not only in basal cells) in normal-appearing mucosa,9 even in patients without his tological evidence of bladder carcinoma. However, the in creasing expression of EGF-R might indicate a malignant potential of the normal mucosa and might be of prognostic value. On the other hand, since this increased EGF-R expres sion especially is found in patients with invasive lesions, it might also indicate that increased EGF-R expression, which is believed to be associated with T C C progression, is a gen eral phenotypic change in the urothelium.
In conclusion, normal mucosa, adjacent to bladder tumors, harbors potential prognostic information. It is unclear whether or how this is related to the progression of transi tional cell carcinoma. Immunohistochemical examination of normal-appearing mucosa in bladder cancer patients with the markers presented here was not conclusive. Our results indicate that the expression of EGF-R in normal mucosa might be of value, but that unambiguous interpretation is not possible.
